Literature DB >> 12756200

Quinol-based metabolic cycle for estrogens in rat liver microsomes.

Laszlo Prokai1, Katalin Prokai-Tatrai, Pal Perjesi, Alevtina D Zharikova, James W Simpkins.   

Abstract

According to a recently reported metabolic pathway, phenolic A-ring estrogens are metabolized in rat liver microsomes partially to the corresponding quinols by cytochrome P450 isoenzymes. We found that these quinols could, in turn, undergo reduction to regenerate the parent estrogens consumed during the metabolic process. Among the tested endogenous reducing agents, NADH and especially NADPH produced a significant extent of reductive conversion. Enzymes available in rat liver microsomes further catalyzed this reaction with 6.5 +/- 1.5 nmol. min(-1). (mg of protein)(-1) measured as the initial rate of estrone formation at 37 degrees C, whereas the initial rate of second-order reaction for the reduction of E1-quinol by a 10-fold excess of NADPH in a microsome-free buffer solution and under identical incubation conditions was 0.62 +/- 0.03 nmol. min(-1). The quinol route is, therefore, unique among estrogen-metabolizing pathways for its bioreversibility due to the facile regeneration of the phenolic A-ring estrogens consumed in the preceding oxidative process.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12756200     DOI: 10.1124/dmd.31.6.701

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  8 in total

Review 1.  Estrogens as neuroprotectants: Estrogenic actions in the context of cognitive aging and brain injury.

Authors:  E B Engler-Chiurazzi; C M Brown; J M Povroznik; J W Simpkins
Journal:  Prog Neurobiol       Date:  2016-02-15       Impact factor: 11.685

2.  Neuroprotective effects of nonfeminizing estrogens in retinal photoreceptor neurons.

Authors:  Everett Nixon; James W Simpkins
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-07-12       Impact factor: 4.799

Review 3.  The assessment of non-feminizing estrogens for use in neuroprotection.

Authors:  Kun Don Yi; Evelyn Perez; Shaohua Yang; Ran Liu; Douglas F Covey; James W Simpkins
Journal:  Brain Res       Date:  2010-11-25       Impact factor: 3.252

Review 4.  Neuroprotection with non-feminizing estrogen analogues: an overlooked possible therapeutic strategy.

Authors:  James W Simpkins; Timothy E Richardson; Kun Don Yi; Evelyn Perez; Douglas F Covey
Journal:  Horm Behav       Date:  2012-04-03       Impact factor: 3.587

5.  Comparison of estrogen-derived ortho-quinone and para-quinol concerning induction of oxidative stress.

Authors:  Nilka M Rivera-Portalatin; José L Vera-Serrano; Katalin Prokai-Tatrai; Laszlo Prokai
Journal:  J Steroid Biochem Mol Biol       Date:  2007-05-17       Impact factor: 4.292

Review 6.  Role of protein phosphatases and mitochondria in the neuroprotective effects of estrogens.

Authors:  James W Simpkins; Kun Don Yi; Shao-Hua Yang
Journal:  Front Neuroendocrinol       Date:  2009-05-03       Impact factor: 8.606

Review 7.  Alcohol withdrawal and brain injuries: beyond classical mechanisms.

Authors:  Marianna E Jung; Daniel B Metzger
Journal:  Molecules       Date:  2010-07-20       Impact factor: 4.411

8.  Mitochondrial superoxide dismutase activation with 17 beta-estradiol-treated human lens epithelial cells.

Authors:  Srinivas Gottipati; Patrick R Cammarata
Journal:  Mol Vis       Date:  2008-05-16       Impact factor: 2.367

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.